Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
07/2003
07/31/2003US20030144487 Directed to luminescent lanthanide compounds with phosphine oxide, phosphine oxide- sulfide, pyridine N-oxide, and phosphine oxide-pyridine N-oxide ligands. It also relates to electronic devices in which the active layer includes a
07/31/2003US20030144440 Phosphorus-containing compositions and their use in hydrocyanation, isomerization and hydroformylation reactions
07/31/2003US20030144264 Carbapenems containing a carboxy substituted phenyl group and useful for treating bacterial infections in mammals and humans
07/31/2003US20030144263 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
07/31/2003US20030144250 Triazole derivatives useful in therapy
07/31/2003US20030144249 Aminoalkylenephosphoxide derivatives, useful as bactericide, fungicide, viricide and parasiticide
07/31/2003US20030144217 Prodrugs of aspartyl protease inhibitors
07/31/2003US20030144139 Novel phosphine compound, transition metal complex containing the same phosphine compound as ligand and asymmetric synthesis catalyst containing the complex
07/31/2003US20030144138 Having chemical selectivity, enantioselectivity, catalytic activity; for use as a catalyst for asymmetric syntheses, especially asymmetric hydrogenation
07/31/2003US20030144137 For use as catalysts in asymmetric reactions, such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation
07/31/2003CA2473960A1 Real-time linear detection probes: sensitive 5'-minor groove binder-containing probes for pcr analysis
07/31/2003CA2473047A1 Phosphinic pseudo-peptide derivatives for selective inhibition of the active c-terminal site of angiotensin converting enzyme (i) (ace)
07/31/2003CA2473029A1 Ruthenium and osmium carbene complexes for use in metathesis
07/31/2003CA2471389A1 Process for the preparation of nonracemic syn-1-(4-hydroxy-phenyl)-2-(4-hydroxy-4-phenyl-piperidin-1yl)-1-propanol compounds
07/30/2003EP1330464A2 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation
07/30/2003EP1330463A2 Beta-substituted beta-aminoethyl phosphonates
07/30/2003EP1184388B1 Sulphostin analogues and processes for the preparation of sulphostin and analogues thereof
07/30/2003EP1112275B1 Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase
07/30/2003CN1433422A Use of supplemental promoter in conjunction with carbon-supported, noble-metal-containing catalyst in liquid phase oxidation reactions
07/30/2003CN1433421A Chemical process and intermediate
07/30/2003CN1433420A Ion liquids derived from lewis acid based on titanium, niobium, tantalum, tin or antimony and uses thereof
07/30/2003CN1433396A Pharmaceutical compounds
07/30/2003CN1433297A Topical compositions comprising protected functional thiols
07/30/2003CN1432573A Fluoric alpha-aminoalkyl phosphonate with agricultural antiviral activity and its synthesis
07/30/2003CN1432539A Neutral scavenger for running water circulating system
07/30/2003CN1116265C Hydroformylation process and catalyst suitable therefor containing phosphorus compounds as ligands
07/29/2003US6600068 Process for preparing ethanebis(methylphosphinic) acid
07/29/2003US6600067 Reacting phosphorous acid (H3PO3) directly with alkynes
07/29/2003US6600036 Treating diseases of the central nervous system.
07/29/2003US6599889 Acyl phosphonate inhibitors of β-lactamases
07/29/2003US6599858 Preparing ammonium glyphosate flakes comprising mixing solid particulate glyphosate acid, water and anhydrous ammonia; drying the reaction product to form, by evaporation of water, a solid deposit on the heated surface
07/29/2003US6599533 Homogenous water-free formulations containing glycerophospholipids and polar or lipophilic substances, method for the production thereof
07/29/2003CA2132982C Catalytic antibodies against cocaine and methods of using and producing same
07/29/2003CA2113914C Phospholipid derivative and liposome containing it
07/24/2003WO2003059921A1 Mmp inhibitors
07/24/2003WO2003059920A1 Additive to lubrication oils
07/24/2003WO2003059898A2 Eponemycin and epoxomicin analogs and uses thereof
07/24/2003WO2003059880A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
07/24/2003WO2003059873A1 Potassium channel modulators
07/24/2003WO2003059855A1 Synthesis of combretastatin a-2 prodrugs
07/24/2003WO2003059824A1 Purification of onium hydroxides by electrodialysis
07/24/2003WO2003059255A2 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol
07/24/2003WO2003031456A3 Ligands for asymmetric reactions
07/24/2003WO2003028713A3 3,4-methylenedioxy-substituted chalcones as therapeutic agents
07/24/2003WO2003011221A3 PREPARATION AND USE OF α-KETO PHOSPHONATES
07/24/2003US20030139626 Process for the preparation of quaternary salt phenolate solutions
07/24/2003US20030139622 Process for the preparation of alk(en)ylphosphoric ester salts
07/24/2003US20030139592 Process for the sulfurization of a phosphorus-containing compound
07/24/2003US20030139485 Organometallic monoacylalkylphosphines
07/24/2003US20030139300 Containing fluorination dithiophosphonate salt
07/24/2003US20030139285 Novel asymmetric phosphine ligand
07/24/2003CA2471309A1 Synthesis of combretastatin a-2 prodrugs
07/24/2003CA2470649A1 Mmp inhibitors
07/23/2003EP1329455A1 Metal carbene complexes, methods and intermediates for making them and their use in metathesis reactions
07/23/2003EP1329450A1 Benzodiazepine derivative
07/23/2003EP1329259A2 Continuous method for hydrolysis of a solvent containing organic compound
07/23/2003EP1328610A1 Phosphate fluorosurfactants for use in carbon dioxide
07/23/2003EP1328533A1 Bridged ylide group containing metal complexes
07/23/2003EP1328532A2 Production of metal chalcogenide nanoparticles
07/23/2003EP1328531A1 Method for producing phosphoric acid esters
07/23/2003EP1328530A1 Method for producing phosphoric acid esters
07/23/2003EP1163246B1 Organic-arsenic compounds
07/23/2003EP0668865B1 Indenyl compounds and catalyst components for the polymerization of olefins
07/23/2003CN1431999A Indole derivatives with vascular damagine activity
07/23/2003CN1431941A 挤压模 Extrusion die
07/23/2003CN1431213A Method for preparing artificial hapten, artificial antigen and specific antibody of chlorpyrifos and its usage
07/22/2003US6596887 Reacting a ruthenium-phosphine complex with a specific optically active chiral diamine to deactivate one of the enantiomers and with another diamine to activate the other enantiomers
07/22/2003US6596865 Method of purifying thiamine phosphates
07/22/2003US6596858 Process for the production of 2-halo-6-aminopurine derivatives
07/22/2003US6596857 Preparation of phosphorothioate oligomers
07/22/2003US6596856 Nucleic acid labeling compounds
07/22/2003US6596711 GABA B receptor agonists for use in the treatment of CNS disorders, such as muscle relaxation in spinal spasticity, cardiovascular disorders, asthma, gut motility disorders such as irritable bowel syndrome and gastroesophogeal reflux
07/22/2003US6596709 6-sulphanoyl-3-quinolylphosphonic acid compounds
07/22/2003US6596522 Compositions and optical methods for determining transmembrane potentials across plasma membrane of biological cells
07/17/2003WO2003057173A2 Broad spectrum inhibitors
07/17/2003WO2003057169A2 4-dedimethylamino tetracycline compounds
07/17/2003WO2003057012A2 S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer
07/17/2003WO2003033140A3 Process and catalyst for dehydrogenating primary alcohols to make carboxylic acid salts
07/17/2003WO2002055495A8 Aryl piperidine derivatives as inducers of ldl-receptor expression
07/17/2003WO2002009723A3 Ammonium salts of hemoglobin allosteric effectors, and uses thereof
07/17/2003US20030135063 Especially Type II diabetes; stimulating the kinase activity of the insulin receptor; activating the insulin receptor
07/17/2003US20030135014 Derived from aryl to aryl coupling of a substituted 2,2'-dihydroxyl-1,1'-binaphthalene or biphenylene and phosphonylated with a diaryloxyphosphite, diarylphosphine or aryloxyphosphinite
07/17/2003US20030135007 Reaction product of a silylamide (e.g., hexamethyldisilazane) and a fluoride (e.g., cesium fluoride or hexakis(dimethylamino)phosphazenium fluoride)
07/17/2003US20030134274 Nucleic acid sequence detection employing probes comprising non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents
07/17/2003US20030133904 Sphingolipids
07/17/2003US20030133872 Radiopharmaceutical agent for the treatment of early stage cancer
07/17/2003CA2472633A1 S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer
07/17/2003CA2472580A1 Broad spectrum inhibitors
07/16/2003EP1327635A1 Preparation of phenylphosphate esters of 4,4'-biphenol
07/16/2003EP1327010A2 Vapor deposition of oxides, silicates and phosphates
07/16/2003EP1326822A2 Ketone compounds and compositions for cholesterol management and related uses
07/16/2003EP1210353B1 Calcium complex of phosphorus containing ethylenediamine derivatives
07/16/2003EP1199927B1 Process for making ammonium glyphosate powder
07/16/2003EP1109789B1 Triptolide prodrugs having high aqueous solubility
07/16/2003EP0832076B1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
07/16/2003CN1430644A Novel phosphorous-nitrogen compounds used as fireproofing agents in thermoplastic molding materials and the production thereof
07/16/2003CN1430622A Reaction systems for making N-(phosphonomethyl) glycine compounds
07/16/2003CN1430621A New process for preparation of vinyl-pyrrolidinone cephalosporine derivatives
07/16/2003CN1429829A Method of preparing 5-carboxy amyl-triphenyl phosphine bromide
07/16/2003CN1429828A Preparation method of high purity soyabean lecithin